scispace - formally typeset
T

Thitima Pengsuparp

Researcher at Chulalongkorn University

Publications -  32
Citations -  1566

Thitima Pengsuparp is an academic researcher from Chulalongkorn University. The author has contributed to research in topics: Programmed cell death & Reverse transcriptase. The author has an hindex of 19, co-authored 32 publications receiving 1431 citations. Previous affiliations of Thitima Pengsuparp include University of Illinois at Chicago.

Papers
More filters
Journal ArticleDOI

In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora

TL;DR: The results indicated that compounds 3 and 4 demonstrated similar activity against HIV-1 reverse transcriptase (RT), with IC50 values of 65 microM and 170 microM, respectively.
Journal ArticleDOI

Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (±)-calanolide A and its enantiomers

TL;DR: The anti-HIV agent (+/-)-calanolide A (1) has been synthesized in a five-step approach starting with phloroglucinol, which includes Pechmann reaction, Friedel-Crafts acylation, chromenylation with 4,4-dimethoxy- 2-methylbutan-2-ol, cyclization, and Luche reduction.
Journal ArticleDOI

Nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase

TL;DR: Nigranoic acid showed activity in several anti-HIV reverse transcriptase and polymerase assays and its structure elucidation and unambiguous NMR spectral assignment were achieved by the combination of 1D- and 2D-NMR techniques with the aid of computer modeling.
Journal ArticleDOI

Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase.

TL;DR: The mechanism of action of 1 beta-hydroxyaleuritolic acid 3-p-Hydroxybenzoate and protolichesterinic acid as HIV-1 RT inhibitors involves nonspecific binding to the enzyme at nonsubstrate binding sites, whereas swertifrancheside inhibits enzyme activity by binding toThe template-primer.
Journal ArticleDOI

Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells

TL;DR: Co-treatment of cisplatin with autophagy inducer, trifluorperazine, could resensitize H460/cis cells to cisPlatin-induced cell death, suggesting the role of autophagosome formation detected by acridine orange staining was dramatically reduced in the resistant cells, suggestingThe role of Autophagy in attenuating of cis platin- induced cell death.